期刊文献+

应用未成熟血小板比例、未成熟血小板绝对值和血栓弹力图评估原发免疫性血小板减少症患者的出血风险 被引量:19

Application of immature platelet fraction 、absolute immature platelet fraction and thrombelastograph on assessment of bleeding risk in patients with immune thrombocytopenia
原文传递
导出
摘要 目的探讨未成熟血小板比例(IPF)、未成熟血小板绝对值(A.IPF)和血栓弹力图(TEG)在原发免疫性血小板减少症(ITP)患者出血倾向评估中的价值。方法采用ITP.BAT出血评分系统对271例ITP患者进行出血评分及出血程度分级,并行IPF、A.IPF检测,其中125例行TEG检测,分析ITP患者出血程度与IPF、A—IPF、TEG各指标的相关性。结果在271例ITP患者中,不同疾病分期和性别患者的出血程度差异无统计学意义(P〉0.05);儿童以轻度出血为主,与成人出血程度差异有统计学意义(P〈0.05);出血程度和血小板计数呈负相关(P〈0.001)。在所有患者、PLT〈30×10^9/L患者以及PLT〈30×10^9/L儿童患者中,血小板计数与IPF呈负相关(P〈0.05),与A-IPF、血栓最大幅度(MA)值呈正相关(P〈0.05)。在所有患者及PLT〈30×10^9/L患者中,出血程度和IPF呈正相关(P〈0.001),与A.IPF、MA值呈负相关(P〈0.001)。在PLT〈30×10^9/L儿童患者中,出血程度与IPF、A.IPF、MA值均无相关性(JD〉0.05)。ROC曲线分析显示IPF、A.IPF、MA值评估ITP患者出血风险效能较好,ROC曲线下面积分别为0.745、0.744、0.813(P〈0.001)。多因素分析显示IPF和MA值是预测ITP患者出血倾向的独立因素,综合诊断ROC曲线下面积0.846(P〈0.001),优于单一指标。结论IPF、A-IPF和MA值能够准确评估ITP患者的出血风险.可以作为治疗的参考指标和疗效的观察指标. Objective To explore the clinical value of immature platelet fraction(IPF), absolute immature platelet fraction (A-IPF) and thrombelastograph (TEG) on assessment of bleeding risk of immune thrombocytopenia (ITP). Methods two hundred and seventy-one patients with ITP were assessed based on ITP-BAT bleeding grading system. IPF, A-IPF were determined in 271 patients ,TEG in 125 patients. The correlations between bleeding grades and IPF, A-IPF, variables of TEG in subgroups were analyzed by statistical method. The predictive value of IPF, A-IPF, and variables of TEG on bleeding risk of ITP patients was evaluated. Results There were no significant differences in bleeding degree in all patients with different gender and disease stage (P〉0.05). Mild bleeding rate in children was higher than that in adult (P〈0.05). PLT inversely correlated with bleeding grade for the entire cohort (P〈0.001). In all subjects, PLT〈 30× 10^9/L and pediatric cohorts with PLT〈 30× 10^9/L, PLT were negatively correlated with IPF (P〈0.05), positive correlated with A-IPF (P〈0.001) and the maximum amplitude (MA) (P〈0.05). Bleeding grades were significantly correlated with IPF, A-IPF, MA in all subjects and patients with PLT〈 30×10^9/L (P〈0.001). IPF, A-IPF and MA did not correlate with bleeding grades in children with PLT〈 30× 10^9/L (/9〉0.05). ROC curve analysis revealed IPF, A-IPF aud MA had better predictive value (AUC 0.745, 0.744, 0.813, P〈0.001 ). Multivariate analysis showed that IPF and MA were independence factors for predicting bleeding risk in ITP patients and comprehensive predictive value was higher (AUC 0.846, P〈 0.001) than single variable. Conclusion IPF, A-IPF and MA could accurately evaluate bleeding risk in ITP patients. It may be considered as reference index of the treatment and observation index of curative effect.
出处 《中华血液学杂志》 CAS CSCD 北大核心 2015年第9期759-764,共6页 Chinese Journal of Hematology
基金 国家自然科学基金(81270581、81470286) 天津市应用基础及前沿技术研究计划重点项目(14JCZDJC35100)
关键词 血小板减少 未成熟血小板比例 血栓弹力图 出血 Thrombocytopenia Immature platelet fraction Thrombelastograph Bleeding
  • 相关文献

参考文献11

  • 1儿童原发性免疫性血小板减少症诊疗建议[J].中华儿科杂志,2013,51(5):382-384. 被引量:215
  • 2Estcourt L J, Stanworth S J, Harrison P, et al. Prospective observa- tional cohort study of the association between thromboelastome- try, coagulation and platelet parameters and bleeding in patients with haematological malignancies- the ATHENA study [J]. Br J Haematol, 2014,166(4):581-591.
  • 3成人原发免疫性血小板减少症诊治的中国专家共识(修订版)[J].中华血液学杂志,2011,32(3):214-216. 被引量:206
  • 4Rodeghiero F, Michel M, Gernsheimer T, et al. Standardization of bleeding assessment in immune thrombocytopenia: report from the International Working Group [J].Blood, 2013,121 ( 14 ) : 2596-2606.
  • 5吕明恩,刘晓帆,付荣凤,孙甜甜,刘文洁,吕翠翠,杨仁池.ITP-BAT出血评分系统在原发免疫性血小板减少症的临床应用价值[J].中华血液学杂志,2014,35(9):812-815. 被引量:9
  • 6Rodeghiero F, Stasi R, Gemsheimer T, et al. Standardization of terminology, definitions and outcome criteria in immune thrombocytopenic purpura of adults and children: report from an international working group [J]. Blood, 2009,113 ( 11 ) :2386- 2393.
  • 7Bolton-Maggs R Severe bleeding in idiopathic thrombocytope- nic purpura [J]. J Pediatr Hematol Oncol,2003,25 Suppl 1:$47- 51.
  • 8Psaila B, Bussel JB, Frelinger AL, et al. Differences in plateletfunction in patients with acute myeloid leukemia and myelodysplasia compared to equally thrombocytopenic patients with immune thrombocytopenia [J]. J Thromb Haemost, 2011, 9( 11 ):2302-2310.
  • 9Fager AM, Wood JP, Bouehard BA, et al. Properties of procoag- ulant platelets: defining and characterizing the subpopulation binding a functional prothrombinase [J]. Arterioscler Thromb Vasc Biol, 2010,30 (12) :2400-2407.
  • 10Adly AA, Ragab IA, Ismail EA, et al. Evaluation of the immature platelet fraction in the diagnosis and prognosis of childhood immune thrombocytopenia [J]. Platelets, 2014,1-6. DOI: 10.3109/09537104.2014.969220.

二级参考文献31

  • 1Yong M, Schoonen WM, Li L, et al. Epidemiology of paediatric immune thrombocytopenia in the General Practice Research Database. Br J Haematol, 2010, 149: 855-864.
  • 2Rosthcj S, Hedlund-Treutiger I, Rajantie J, et al. Duration and morbidity of newly diagnosed idiopathic thrombocytopenic purpura in children : A prospective nordic study of an unselected cohort. J Pediatr, 2003, 143:302-307.
  • 3Kiihne T, Buchanan GR, Zimmetlan S, et al. A prospective comparative study of 2540 infants and children with newly diagnosed idiopathic thrombocytopenic purpura (ITP) from the intercontinental childhood ITP study group. J Pediatr, 2003, 143 : 605 -608.
  • 4British Committee for Standards in Hematology General Hematology Task Force. Guidelines for the investigation and management of idiopathic thrombocytopenic purpura in adults, children and in pregnancy. Br J Haematol. 2003. 120:574-596.
  • 5Geddis AE, Balduini CL. Diagnosis of immune thrombocytopenicpurpura in children. Curr Opin Hematol, 2007,14:520-525.
  • 6Rodeghiero F, Stasi R, Gernsheimer T, et al. Standardization of terminology, definitions and outcome criteria in immune thrombocytopenie purpura of adults and children: report from an international working group. Blood, 2009, 113:2386-2393.
  • 7Blanehette V, Carcao M. Approach to the investigation and management of immune thrombocytopenie purpura in children. Semin Hematol, 2000,37:299-314.
  • 8Beck CE, Nathan PC, Parkin PC, et al. Corticosteroids versus intravenous immune globulin for the treatment of acute immune thrombocytopenic purpura in children: a systematic review and meta-analysis of randomized controlled trials. J Pediatr, 2005, 147:521-527.
  • 9Gaines AR. Disseminated intravascular coagulation associated with acutehemoglobinemia or hemoglobinuria following Rh (0) (D) immune globulin intravenous administration for immune thrombocytopenic purpura. Blood, 2005,106 : 1532-1537.
  • 10Hedlund-Treutiger I, Henter JI, Elinder G. Randomized study of IVIg and high-dose dexamethasone therapy for children with chronic idiopathic thrombocytopenic purpura. J Pediatr Hematol Oncol, 2003, 25:139-144.

共引文献424

同被引文献121

引证文献19

二级引证文献150

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部